Rockwell Medical
RMTI
53 hedge funds and large institutions have $37.5M invested in Rockwell Medical in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 3 closing their positions.
733% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 3
610% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $277K
240% more capital invested
Capital invested by funds: $11M → $37.5M (+$26.5M)
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
71% more funds holding
Funds holding: 31 → 53 (+22)
0.97% more ownership
Funds ownership: 2.07% → 3.04% (+0.97%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
+$2M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.37M |
| 3 |
AC
Armistice Capital
New York
|
+$968K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$598K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$481K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$250K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$216K |
| 3 |
RB
Richmond Brothers
Jackson,
Michigan
|
-$72.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$26.5K |
| 5 |
TIA
Traphagen Investment Advisors
Oradell,
New Jersey
|
-$19.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LIS
51
Legacy Investment Solutions
Meridian,
Idaho
| $79 | +$81 | +3 | New |
|
|
LWMI
52
Legacy Wealth Management (Idaho)
Boise,
Idaho
| $79 | +$81 | +3 | New |
|
|
TIA
53
Traphagen Investment Advisors
Oradell,
New Jersey
| – | -$19.5K | -1,110 | Closed |
|
54
Group One Trading
Chicago,
Illinois
| – | -$780 | -29 | Closed |
|
RMTI Hedge Fund Activity: Q3 2024 in Review
53 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q3 2024, worth a combined $37.5M — up 240% from $11M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new RMTI positions and 3 closed out — a net gain of 22 holders — while 18 added to existing stakes and 6 trimmed.
The largest buyer was Globeflex Capital, opening a new position worth an estimated $2M. The largest seller was GSA Capital Partners, cutting an estimated $250K.
- 53 institutional investors held Rockwell Medical (RMTI) as of Q3 2024, up from 31 in Q2 2024.
- Funds reported $37.5M of Rockwell Medical stock for Q3 2024, up 240% quarter-over-quarter.
- 25 funds opened new Rockwell Medical positions in Q3 2024 and 3 closed out, a net change of +22 holders.
- The largest Rockwell Medical buyer in Q3 2024 was Globeflex Capital, an estimated $2M added.
- The largest Rockwell Medical seller in Q3 2024 was GSA Capital Partners, an estimated $250K sold.
Based on aggregated 13F filings for Q3 2024.